OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association Between Buprenorphine for Opioid Use Disorder and Mortality Risk
J. Priyanka Vakkalanka, Brian C. Lund, Stephan Arndt, et al.
American Journal of Preventive Medicine (2021) Vol. 61, Iss. 3, pp. 418-427
Open Access | Times Cited: 22
J. Priyanka Vakkalanka, Brian C. Lund, Stephan Arndt, et al.
American Journal of Preventive Medicine (2021) Vol. 61, Iss. 3, pp. 418-427
Open Access | Times Cited: 22
Showing 22 citing articles:
Buprenorphine precipitated opioid withdrawal: Prevention and management in the ED setting
Anthony Spadaro, Brit Long, Alex Koyfman, et al.
The American Journal of Emergency Medicine (2022) Vol. 58, pp. 22-26
Open Access | Times Cited: 24
Anthony Spadaro, Brit Long, Alex Koyfman, et al.
The American Journal of Emergency Medicine (2022) Vol. 58, pp. 22-26
Open Access | Times Cited: 24
Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone
Anna Kline, Jill M. Williams, Marc L. Steinberg, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 149, pp. 209028-209028
Open Access | Times Cited: 12
Anna Kline, Jill M. Williams, Marc L. Steinberg, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 149, pp. 209028-209028
Open Access | Times Cited: 12
Healthcare Expenditures Associated With Implementing an External Facilitation Program to Increase the Prescribing of Medications Used for the Treatment of Opioid Use Disorder Among Veterans
A Esmaeili, Hildi Hagedorn, Carla Costa Garcia, et al.
Substance Abuse (2025)
Closed Access
A Esmaeili, Hildi Hagedorn, Carla Costa Garcia, et al.
Substance Abuse (2025)
Closed Access
The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study
Nicholas A. Livingston, Michael Davenport, Michael A. Head, et al.
Drug and Alcohol Dependence (2022) Vol. 241, pp. 109678-109678
Open Access | Times Cited: 14
Nicholas A. Livingston, Michael Davenport, Michael A. Head, et al.
Drug and Alcohol Dependence (2022) Vol. 241, pp. 109678-109678
Open Access | Times Cited: 14
Eliminate the buprenorphine DEA X waiver: Justification using a policy analysis approach
Katie Fitzgerald Jones, Monica O’Reilly Jacob, Joanne Spetz, et al.
Journal of Nursing Scholarship (2023) Vol. 55, Iss. 3, pp. 655-664
Closed Access | Times Cited: 7
Katie Fitzgerald Jones, Monica O’Reilly Jacob, Joanne Spetz, et al.
Journal of Nursing Scholarship (2023) Vol. 55, Iss. 3, pp. 655-664
Closed Access | Times Cited: 7
Improving access to care via psychiatric clinical pharmacist practitioner collaborative management of buprenorphine for opioid use disorder
Haley Pals, Jeffrey Bratberg
Journal of the American Pharmacists Association (2022) Vol. 62, Iss. 4, pp. 1422-1429
Closed Access | Times Cited: 9
Haley Pals, Jeffrey Bratberg
Journal of the American Pharmacists Association (2022) Vol. 62, Iss. 4, pp. 1422-1429
Closed Access | Times Cited: 9
Acute pain service reduces barriers to buprenorphine/naloxone initiation by using regional anesthesia techniques
Alice Seol, John Chan, Brittni Micham, et al.
Regional Anesthesia & Pain Medicine (2023) Vol. 48, Iss. 8, pp. 425-427
Closed Access | Times Cited: 4
Alice Seol, John Chan, Brittni Micham, et al.
Regional Anesthesia & Pain Medicine (2023) Vol. 48, Iss. 8, pp. 425-427
Closed Access | Times Cited: 4
Peer Providers and Linkage with Buprenorphine Care after Hospitalization: A Retrospective Cohort Study
Helen E. Jack, Eric D. Denisiuk, Brett Collins, et al.
Substance Abuse (2022) Vol. 43, Iss. 1, pp. 1308-1316
Open Access | Times Cited: 7
Helen E. Jack, Eric D. Denisiuk, Brett Collins, et al.
Substance Abuse (2022) Vol. 43, Iss. 1, pp. 1308-1316
Open Access | Times Cited: 7
A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder
James C. Miller, Michael A. Brooks, Kelly E. Wurzel, et al.
Drugs in R&D (2023) Vol. 23, Iss. 4, pp. 339-362
Open Access | Times Cited: 3
James C. Miller, Michael A. Brooks, Kelly E. Wurzel, et al.
Drugs in R&D (2023) Vol. 23, Iss. 4, pp. 339-362
Open Access | Times Cited: 3
Suicide within 1 year of non-fatal overdose: Risk factors and risk reduction with medications for opioid use disorder
Molly Nowels, Paul R. Duberstein, Stephen Crystal, et al.
General Hospital Psychiatry (2023) Vol. 86, pp. 24-32
Closed Access | Times Cited: 2
Molly Nowels, Paul R. Duberstein, Stephen Crystal, et al.
General Hospital Psychiatry (2023) Vol. 86, pp. 24-32
Closed Access | Times Cited: 2
Shorter and longer-term risk for non-fatal suicide attempts among male U.S. military veterans after discharge from psychiatric hospitalization
Peter C. Britton, Dev Crasta, Kipling M. Bohnert, et al.
Journal of Psychiatric Research (2021) Vol. 143, pp. 9-15
Closed Access | Times Cited: 4
Peter C. Britton, Dev Crasta, Kipling M. Bohnert, et al.
Journal of Psychiatric Research (2021) Vol. 143, pp. 9-15
Closed Access | Times Cited: 4
Fibromyalgia is associated with increased odds of prior pain-precipitated relapse among non-treatment-seeking individuals with opioid use disorder
O. Hall, Pooja Lagisetty, J.L. Rausch, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access
O. Hall, Pooja Lagisetty, J.L. Rausch, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access
The Association Between Telehealth Use During Buprenorphine Treatment for Opioid Use Disorder and Clinical Outcomes: A Retrospective Cohort Study
J. Priyanka Vakkalanka, Brian C. Lund, Stephan Arndt, et al.
Telemedicine Journal and e-Health (2024)
Closed Access
J. Priyanka Vakkalanka, Brian C. Lund, Stephan Arndt, et al.
Telemedicine Journal and e-Health (2024)
Closed Access
Buprenorphine use and setting type among reproductive-aged women self-reporting nonmedical prescription opioid use
Carla L. DeSisto, Mishka Terplan, Akadia Kacha-Ochana, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 155, pp. 209083-209083
Closed Access | Times Cited: 1
Carla L. DeSisto, Mishka Terplan, Akadia Kacha-Ochana, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 155, pp. 209083-209083
Closed Access | Times Cited: 1
The Effect of Peer Support on Treatment Engagement for Opioid Use Disorder
Michelle M. Zuccarini, Cate Stiller
Journal of the American Psychiatric Nurses Association (2022) Vol. 30, Iss. 3, pp. 709-715
Closed Access | Times Cited: 2
Michelle M. Zuccarini, Cate Stiller
Journal of the American Psychiatric Nurses Association (2022) Vol. 30, Iss. 3, pp. 709-715
Closed Access | Times Cited: 2
Current and emerging pharmacotherapies for opioid dependence treatments in adults: a comprehensive update
Jonna M. Leyrer‐Jackson, Amanda M. Acuña, M. Foster Olive
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 16, pp. 1819-1830
Open Access | Times Cited: 2
Jonna M. Leyrer‐Jackson, Amanda M. Acuña, M. Foster Olive
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 16, pp. 1819-1830
Open Access | Times Cited: 2
Association between clinically recognized suicidality and subsequent initiation or continuation of medications for opioid use disorder
Madeline C. Frost, Julie Richards, John R. Blosnich, et al.
Drug and Alcohol Dependence (2022) Vol. 237, pp. 109521-109521
Open Access | Times Cited: 1
Madeline C. Frost, Julie Richards, John R. Blosnich, et al.
Drug and Alcohol Dependence (2022) Vol. 237, pp. 109521-109521
Open Access | Times Cited: 1
Can buprenorphine reduce suicide mortality?
Leo Sher
Acta Psychiatrica Scandinavica (2022) Vol. 147, Iss. 1, pp. 3-5
Closed Access | Times Cited: 1
Leo Sher
Acta Psychiatrica Scandinavica (2022) Vol. 147, Iss. 1, pp. 3-5
Closed Access | Times Cited: 1
Continuation of Buprenorphine During Hospitalization and Subsequent Retention in Therapy: an Observational Study in Veterans Administration Hospitals
Hilary J. Mosher, Katherine Hadlandsmyth, Bruce Alexander, et al.
Journal of General Internal Medicine (2023) Vol. 39, Iss. 2, pp. 207-213
Closed Access
Hilary J. Mosher, Katherine Hadlandsmyth, Bruce Alexander, et al.
Journal of General Internal Medicine (2023) Vol. 39, Iss. 2, pp. 207-213
Closed Access
Rates of receiving medication for opioid use disorder and opioid overdose deaths during the early synthetic opioid crisis: a county-level analysis.
Julián Santaella-Tenorio, Ariadne Rivera‐Aguirre, Staci A. Hepler, et al.
Epidemiology (2023) Vol. 36, Iss. 2, pp. 186-195
Closed Access
Julián Santaella-Tenorio, Ariadne Rivera‐Aguirre, Staci A. Hepler, et al.
Epidemiology (2023) Vol. 36, Iss. 2, pp. 186-195
Closed Access
Predictors of Opioid Overdose During the COVID-19 Pandemic: The Role of Relapse, Treatment Access and Non-Prescribed Suboxone
Anna Kline, Jill M. Williams, Marc L. Steinberg, et al.
SSRN Electronic Journal (2022)
Closed Access
Anna Kline, Jill M. Williams, Marc L. Steinberg, et al.
SSRN Electronic Journal (2022)
Closed Access
Collaborative approach to harm reduction by managed care pharmacy team for populations with substance use disorder
Oyinda Osibanjo, Rob Reinhardt, Shane Clemans, et al.
Journal of the American Pharmacists Association (2022) Vol. 63, Iss. 1, pp. 396-402
Closed Access
Oyinda Osibanjo, Rob Reinhardt, Shane Clemans, et al.
Journal of the American Pharmacists Association (2022) Vol. 63, Iss. 1, pp. 396-402
Closed Access
